Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Der globale Markt für Facial Serums wurde im Jahr 2025 auf 5,0 Milliarden US-Dollar geschätzt und wird bis 2032 auf 7,2 Milliarden US-Dollar wachsen, mit einem jährlichen Wachstum von 5,2 %. Die Marktentwicklung wird durch verschiedene Faktoren getrieben, einschließlich der Entwicklung in der dermatologischen Forschung, dem Aufkommen von sauberen Schönheitsprodukten und der zunehmenden Nachfrage nach gezielten Hautpflegelösungen. Der Artikel enthält auch Informationen über die Markttrends, -faktoren und -prognosen sowie eine Analyse der wichtigsten Spieler im Markt.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Der globale Markt für Männer-Skincare-Produkte boomt aufgrund sich verändernder sozialer Normen, wachsender Aufmerksamkeit für die Pflege der Haut und urbaner Lebensstile. Der Bericht analysiert den globalen Markt für Männer-Skincare-Produkte und präsentiert Prognosen bis 2031.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Für Investoren ist die schwache Aktienentwicklung von Beiersdorf ein Anlass, sich über die jüngsten Entwicklungen zu informieren. Die Firma hat in den letzten Monaten negative Renditen verzeichnet und auch im Vergleich zum Vorjahr ist das Ergebnis nicht positiv. Trotzdem zeigt der Konzern eine starke Bilanz mit einem Umsatz von 9,85 Mrd. Euro und einer Nettoausfallrendite von 939 Mio. Euro. Die Frage ist nun, ob die aktuelle Bewertung des Unternehmens den tatsächlichen Wert widerspiegelt.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Wachsende Nachfrage nach personalisierten Rasierprodukten, natürlichen Inhaltsstoffen und umweltfreundlicher Verpackung in männlichen Toilettensartikeln präsentiert wichtige Chancen. Eine zunehmende Konzentration auf persönliche Hygiene und Grooming sowie die Notwendigkeit nachhaltiger Verpackungen kann das Wachstum in den Regionen Asien-Pazifik, Amerika, Europa und dem Nahen Osten treiben.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

This article first appeared on GuruFocus.

Group Organic Net Sales Decline: 4.6% in Q1 2026. Consumer Business Organic Net Sales Decline: 4.7% in Q1 2026. Derma Organic Sales Growth: 8.2% in Q1 2026. Health Care Organic Sales Growth: 1.9% in Q1 2026. NIVEA Net Sales Decline: 7% in Q1 2026. La Prairie Net Sales Decline: 14.9% in Q1 2026. Tesa Organic Net Sales Decline: 4.3% in Q1 2026. Consumer Business Net Sales: EUR 2.077 billion in Q1 2026. Tesa Net Sales: EUR 407 million in Q1 2026. Group Net Sales: EUR 2.484 billion in Q1 2026. NIVEA Year-to-Date Sell-Out Growth: 1.7%. North America Organic Net Sales Growth (Excluding Disruptions): 3.2%. Africa, Asia, Australia Growth (Excluding Middle East): 1.1%.

Warning! GuruFocus has detected 6 Warning Signs with BOM:511742. Is BDRFF fairly valued? Test your thesis with our free DCF calculator.

Release Date: April 21, 2026

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

The Derma business achieved an outstanding 8.2% organic sales growth, significantly outperforming the market. Eucerin and Aquaphor brands are driving growth in key markets such as North America, Brazil, and China. NIVEA's rebalancing strategy is showing early signs of success, with a 1.7% year-to-date sell-out growth. La Prairie's retail sales, excluding disruptions, grew close to 10% in Q1, indicating strong underlying demand. Beiersdorf AG (BDRFF) is maintaining its 2026 guidance, expecting net sales to be flat to slightly growing organically.

Negative Points

The company experienced an organic net sales decline of 4.6% at the group level in Q1. NIVEA and La Prairie faced significant headwinds, with net sales declining by 7% and 14.9%, respectively. Retailer conflicts in Europe, particularly in Germany and France, are impacting NIVEA's sales performance. The Middle East crisis contributed to a 50% decline in net sales for NIVEA and Eucerin in the region. The automotive sector remains challenging for the tesa business, impacting overall performance.

Q & A Highlights

Q: Can you provide the NIVEA full Q1 number and discuss the cost situation given higher inputs? A: The market share data for NIVEA is only available until the end of February. The decline in net sales is due to innovation phasing, flat market dynamics, the Middle East crisis, and retailer conflicts. Regarding costs, the direct impact of oil and gas is limited, primarily affecting logistics. We are monitoring the situation and preparing for potential cost increases.

Q: Could you elaborate on the retailer disputes and their resolution? A: The disputes are under negotiation, primarily with retailers in France and Germany who want us to decrease prices. We are not willing to do so and are hopeful for a resolution in the coming weeks.

Story Continues

Q: How do you maintain confidence in your full-year guidance given the slow start? A: We are maintaining our guidance for 2026. The Derma segment shows strong growth, and we expect improvements in La Prairie and NIVEA. The sell-out dynamics are positive, and we anticipate a better Q2 performance.

Q: What impact has the Middle East crisis had, and what are your expectations for the second quarter? A: The Middle East crisis had a 170 basis points impact on the Africa, Asia, Australia region, equating to about 40 basis points at the group level. We are managing the situation creatively to continue serving our consumers.

Q: Can you discuss the NIVEA recalibration strategy and its marketing support? A: The recalibration involves reallocating marketing efforts to body care and deodorants, which require less investment than face care. This strategy allows us to maintain a stable marketing budget while improving sell-out performance.

Q: What are the risks to your market share in Europe, particularly in Germany, due to increased competition? A: We have reacted by investing more in core categories like body and accessible face care. We are optimistic about regaining market share with new product launches and strategic marketing efforts.

Q: Are you considering pricing actions to offset input cost pressures in H2? A: We are evaluating various scenarios for cost impacts and potential pricing actions. These have not been built into our guidance, and we are managing the situation as it evolves.

Q: Is there any cannibalization between NIVEA Epicelline and Eucerin Epicelline products? A: There is no cannibalization between the two products. They are sold in different retail environments, and both are performing well with strong repurchase rates.

Q: What measures are you taking in response to higher oil prices and currency costs? A: We are exploring various scenarios and managing travel and overhead costs. Our US tariffs impact is limited due to our production footprint in the US and Mexico.

Q: What was the issue with US department stores, and is it resolved? A: The issue with Saks Avenue has been resolved, and we are back to normal operations, selling La Prairie and Chantecaille in all Saks stores in the US.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Beiersdorf Aktiengesellschaft logo

Beiersdorf Aktiengesellschaft (ETR:BEI) reported a challenging start to 2026 but said results were broadly in line with expectations, supported by continued strength in its Derma business and improving sell-out trends despite weak first-quarter net sales.

On the company’s Q1 2026 conference call, CEO Vincent Warnery said management had anticipated a difficult first quarter, citing headwinds at La Prairie and Nivea, while CFO Astrid Hermann highlighted foreign exchange pressure and several region-specific disruptions. The company confirmed its full-year 2026 guidance.

Q1 sales: organic decline at group level

→ TSMC: Despite Post-Earnings Fall, Signs of AI Weakness are Scant

Warnery said group organic net sales declined 4.6% in Q1 2026. The consumer business fell 4.7% organically, while Tesa posted an organic net sales decline of 4.3%.

Within consumer, performance diverged by division:

Derma grew 8.2% organically. Healthcare increased 1.9% on what Warnery described as a “difficult prior comparison base.” Nivea declined 7% organically. La Prairie declined 14.9% organically.

→ $39 Trillion Debt Signal: 3 TIPS ETFs to Hedge Persistent Inflation

Hermann said consumer business net sales were EUR 2.077 billion in the quarter, and Tesa net sales were EUR 407 million. Group net sales totaled EUR 2.484 billion. She added that adverse foreign exchange effects weighed on nominal performance, with nominal sales down 7.7% for both consumer and Tesa.

Derma outperforms as Eucerin and Aquaphor expand

Warnery repeatedly pointed to Derma as a key growth driver, saying the business “again significantly outperformed the Derma market,” which he characterized as growing at low single-digit rates. He credited momentum to innovation and expansion into “white spaces.”

→ Could These 3 New-to-Market Quantum Computing Firms Threaten D-Wave?

He highlighted ingredients including Epicelline and Thiamidol and said consumers are increasingly seeking “science-backed, efficacious Derma products.”

By region, Warnery cited:

North America: Derma’s largest region, with 7% organic growth, driven by a “double-digit Aquaphor performance” and continued strength in Eucerin face care. Brazil: Eucerin net sales “more than double[d]” in Q1, with Warnery saying the brand is “close to taking the number 3 position” five years after being number 15. China: continued “high double-digit growth,” which he attributed to the rollout of Thiamidol.

Addressing a question later in the call, Warnery also said Eucerin showed “absolutely zero” cannibalization from Nivea Epicelline, noting that the products are typically sold in different channels (mass market versus pharmacies). He added that Eucerin Epicelline is expanding with additional SKUs such as day and night products.

Story Continues

La Prairie hit by U.S. department store and China travel retail disruption

Warnery said La Prairie’s Q1 results were affected by “disruptions in the U.S. department store channel as well as travel retail in China,” contributing to the 14.9% organic net sales decline. However, he said this did not reflect underlying demand, stating that retail sales excluding the disruptions “grew close to 10%” in the quarter and that China was a key driver for the “fourth consecutive quarter.”

During the Q&A, Warnery said Saks Fifth Avenue had been a specific issue in the U.S. department channel. “It’s public knowledge that Saks Fifth Avenue was in a difficult situation and we were not selling anything to Saks Fifth Avenue until we had an agreement on the overdues,” he said, adding that the issue is now resolved and shipments have resumed.

Warnery also said La Prairie is planning a “more affordable line,” which he said could broaden distribution, including to Amazon in the U.S. and other retailers that are not currently served due to La Prairie’s pricing.

Nivea rebalancing: sell-out improves despite weak net sales

Nivea remained the biggest drag in Q1, with net sales down 7% organically. Warnery attributed the pressure to a combination of market and internal factors, including flat mass-market volumes, tougher prior-year comparisons, and innovation phasing. He said sell-in for major launches Epicelline and Derma Control occurred in Q4 2025, with sell-out absorbed in Q1 2026.

Warnery also flagged retailer disputes in Europe. He said some retailers in Germany and France were pushing for price decreases, which the company refused, and that negotiations were ongoing. Responding to another analyst, he broke down the gap between reported Nivea net sales and sell-out: with Nivea down 7% in Q1 versus year-to-date sell-out growth of 1.7%, he attributed roughly 2 percentage points to innovation phasing, 2 points to retailer conflicts, about 50 basis points to the Middle East, and “the rest” to core business weakness that has not yet returned to growth.

Warnery said the company is implementing a three-pillar “rebalancing” strategy for Nivea:

Portfolio: broaden focus across face care, body care, and deodorants. Accessible face care: increase emphasis on more affordable face care alongside premium lines such as Luminous and Epicelline. Local relevance: give key markets (including China, the U.S., India, Japan, and Brazil) greater flexibility in execution within what he called “localization within a frame.”

He provided examples including increased body care marketing in emerging markets (with market shares moving into positive territory in value and volume), deodorants in Europe supported by the Derma Control launch, and local adaptation of Luminous through the Luminous Glow line, citing Thailand as a “proof point” where sachet formats and influencer activation helped the product become the “number one serum in the market.”

On Epicelline, Warnery said repurchase metrics look “promising,” adding that initial repurchase rates for the Nivea Epigenetic Serum in Europe are comparable to Eucerin’s in 2025. Later, he said Nivea repurchase rates were “between 35%-48%, depending on the countries.”

Hermann said Nivea’s decline was “primarily driven by volume,” adding that the impact was broad across regions, with some country-level bright spots.

Regional factors: Middle East disruption, travel retail accounting, and Coppertone phasing

Hermann said regional consumer performance was “mostly attributable” to Nivea and La Prairie, but pointed to additional headwinds:

North America was affected by La Prairie disruption and Coppertone, which she said was impacted by portfolio streamlining toward the sports segment and promotional phasing. Excluding those factors, she said North America’s organic growth would have been +3.2%, mainly driven by Derma. Western Europe was hit by the disruption of China travel retail, which is recorded in Western Europe for La Prairie. Hermann quantified this as a 130 basis point headwind in Q1. Africa, Asia, Australia faced a 170 basis point headwind from the Middle East crisis; excluding the Middle East, she said the region would have grown 1.1%.

Warnery later characterized the Middle East as about 3% of sales and said the company saw a roughly -50% decline there, describing it as a net sales issue rather than a sell-out problem because the company has been “able to find ways to stock the retailer in due time,” including rerouting logistics.

On Coppertone, Warnery told analysts Q1 weakness reflected phasing after a major U.S. customer ordered earlier than expected in December, supporting Q4 but depressing Q1 net sales. He said sell-out in the sports focus area was up 7.6%, which he described as the best performance since Beiersdorf acquired the brand.

Tesa: prior-year electronics comparison weighs on Q1

Hermann said Tesa’s Q1 organic sales decline was largely due to a high prior-year comparison in electronics, tied to customer production footprint shifts and adjusted order patterns. She said the automotive sector remained challenging, but Tesa outperformed the market “especially in applications for new energy vehicles.”

Guidance reiterated; cost outlook monitored

Warnery said the company is confirming its 2026 outlook despite the Q1 decline. Beiersdorf expects organic net sales to be “flat to slightly growing” for both consumer and Tesa, with an EBIT margin excluding special factors “slightly below the previous year,” including at group level.

On costs, Hermann said the direct impact of oil and gas is “relatively limited,” primarily affecting logistics, and has been “manageable so far.” However, she said the company is running multiple scenarios and warned that prolonged disruption “could trigger significant cost increases,” potentially requiring tools to offset pressure. She later said the company is protected in the near term by contracts but could face more pressure when negotiating for the second half, adding that pricing could be considered if conditions persist.

Looking ahead, Warnery said he expects Q2 to be “flattish back to growth, slight growth,” supported by Derma and improvement in La Prairie, Chantecaille, and Nivea, while noting the importance of the sun care season following strong performance in the prior two years.

About Beiersdorf Aktiengesellschaft (ETR:BEI)

Beiersdorf Aktiengesellschaft, together with its subsidiaries, manufactures and distributes consumer goods in Europe, the Americas, Africa, Asia, and Australia. It operates in two segments, Consumer Business and Tesa Business. The Consumer Business Segment offers skin and body care products. The Tesa Business segment provides adhesive tapes and self-adhesive solutions for industries, craft businesses, and consumers. This segment offers its system solutions to the automotive, electronics, printing and paper, and building and construction industries.

The article "Beiersdorf Aktiengesellschaft Q1 Earnings Call Highlights" was originally published by MarketBeat.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Beiersdorf Aktiengesellschaft (ETR:BEI) is about to trade ex-dividend in the next 3 days. Typically, the ex-dividend date is two business days before the record date, which is the date on which a company determines the shareholders eligible to receive a dividend. The ex-dividend date is important because any transaction on a stock needs to have been settled before the record date in order to be eligible for a dividend. Accordingly, Beiersdorf investors that purchase the stock on or after the 24th of April will not receive the dividend, which will be paid on the 28th of April.

The company's next dividend payment will be €1.00 per share, on the back of last year when the company paid a total of €1.00 to shareholders. Last year's total dividend payments show that Beiersdorf has a trailing yield of 1.3% on the current share price of €78.54. If you buy this business for its dividend, you should have an idea of whether Beiersdorf's dividend is reliable and sustainable. So we need to check whether the dividend payments are covered, and if earnings are growing.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Dividends are typically paid from company earnings. If a company pays more in dividends than it earned in profit, then the dividend could be unsustainable. Beiersdorf has a low and conservative payout ratio of just 24% of its income after tax. A useful secondary check can be to evaluate whether Beiersdorf generated enough free cash flow to afford its dividend. Over the last year it paid out 69% of its free cash flow as dividends, within the usual range for most companies.

It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.

See our latest analysis for Beiersdorf

Click here to see the company's payout ratio, plus analyst estimates of its future dividends.XTRA:BEI Historic Dividend April 20th 2026

Have Earnings And Dividends Been Growing?

Stocks in companies that generate sustainable earnings growth often make the best dividend prospects, as it is easier to lift the dividend when earnings are rising. If business enters a downturn and the dividend is cut, the company could see its value fall precipitously. Fortunately for readers, Beiersdorf's earnings per share have been growing at 12% a year for the past five years. Beiersdorf is paying out a bit over half its earnings, which suggests the company is striking a balance between reinvesting in growth, and paying dividends. Given the quick rate of earnings per share growth and current level of payout, there may be a chance of further dividend increases in the future.

Story Continues

Another key way to measure a company's dividend prospects is by measuring its historical rate of dividend growth. In the last 10 years, Beiersdorf has lifted its dividend by approximately 3.6% a year on average. It's good to see both earnings and the dividend have improved - although the former has been rising much quicker than the latter, possibly due to the company reinvesting more of its profits in growth.

The Bottom Line

Has Beiersdorf got what it takes to maintain its dividend payments? From a dividend perspective, we're encouraged to see that earnings per share have been growing, the company is paying out less than half of its earnings, and a bit over half its free cash flow. Beiersdorf looks solid on this analysis overall, and we'd definitely consider investigating it more closely.

Curious what other investors think of Beiersdorf? See what analysts are forecasting, with this visualisation of its historical and future estimated earnings and cash flow.

If you're in the market for strong dividend payers, we recommend checking our selection of top dividend stocks.

Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

L’Oreal, Unilever, Mars & Beiersdorf first to take back control of AI Visibility

LONDON & TORONTO, March 12, 2026--(BUSINESS WIRE)--Azoma, the pioneers of Agentic Commerce Optimization, today launched Agentic Merchant Protocol (AMP), the powerful new foundational platform empowering retailers and brands to retain control of their product catalogues. Early adopters include some of the world's most recognisable consumer brands and brand owners, such as Mars, L'Oréal, Unilever, Beiersdorf and Reckitt.

Adopting AMP gives early adopters, including major grocery brands, retailers and electronics manufacturers, the ability to differentiate their offers and avoid lock-in to AI providers.

Agentic commerce has crossed a tipping point. On Black Friday 2025 AI chatbots and agents drove an estimated $14.2B in sales globally, over $3B in the U.S. alone. Consumers no longer browse static product pages. Increasingly, they ask agents questions, compare options and evaluate synthesized product recommendations. In effect, machines help them decide what to buy.

Brand representation cannot be left to chance

Platform-specific protocols, like OpenAI ACP and Google’s UCP, quickly connect product data to buyer discovery and checkout workflows. They do not guarantee how brands are represented. The risk is that ‘black boxes’ weigh product data incorrectly, or ignore contradictory information elsewhere online to present offerings out of the context which the seller intended. Even after brands push their information through these channels, AI agents will still form responses by drawing from data across the wider web - sources entirely outside the brand's control.

Just as brands once had to go beyond a single retailer and ensure their product information was accurate everywhere it appeared online, they now need a way to distribute and orchestrate their brand intelligence across the entire agentic ecosystem. That is what AMP delivers.

Max Sinclair, CEO of Azoma commented: "AMP breaks the foundations of traditional ecommerce. For decades, marketplaces like Amazon and Walmart acted as gatekeepers by controlling product detail pages, rankings, and distribution. Brands optimized a finite set of endpoints: PDPs, ads, search results. In an agentic world, those fixed pages no longer exist."

He added, "The fact that businesses like L'Oréal, Unilever, Mars & Beiersdorf have moved so quickly to adopt AMP tells you everything about the urgency they feel. These are companies that have spent decades building brand equity - they're not about to hand control of how their products are represented to an AI black box."

Story Continues

The savvy merchant’s choice

OpenAI and Google are racing to establish the consumer agent of choice for commerce. Merchants lack a neutral, enterprise-grade system focused on their needs. Brand control, consistency, compliance and predictability vary across all agentic surfaces. Azoma takes the opposite approach by focusing on merchant needs rather than consumer experiences.

Sinclair added, "AMP radically improves the AI visibility of product information, guaranteeing agents will weigh it correctly. For enterprise brands, this is an existential change. They can now retain control over channels, messaging, accuracy and compliance. Their products are now represented by whatever information agents find and synthesize, often from unverified or outdated sources."

The missing layer in agentic commerce - how AMP works

Canonical, machine-native product catalogues Enriched with brand guidelines, compliance guardrails, target personas, competitive context, and availability rules

Programmatic Open Web distribution Co-ordinated across the open web and agent ecosystems to ensure relevant product knowledge surfaces where agents reason and decide

Contextual prioritization of content Information distribution guided by persona-level signals to determine which buyer questions and answers matter, which product attributes and content to refresh

Agent-agnostic interface Interchangeable chat-based agents and marketplace assistants to reduce dependence on any one platform’s incentives or roadmap.

Independent enterprise-first brand amplification

Azoma’s Agentic Merchant Protocol is an independent, enterprise-first protocol that gives brands and retailers a single system to define how their product catalogues are understood, reasoned over, and acted upon by machines across every AI agent and the broader online sources that inform from. Azoma does not replace ACP or UCP. It sits above them.

The Azoma protocol allows merchants to feed catalogue product intelligence once, handling distribution everywhere, including agent platforms via ACP and UCP and by shaping the broader online footprint. With this move, Azoma is laying out its plans to become the system of record for agentic commerce. Enterprises define their product catalogues, brand guidelines, regulatory and compliance requirements, and the protocol ensures this intelligence is syndicated across the agentic ecosystem.

​​"We're proud to be working with some of Britain and Europe's most iconic consumer brands from day one," added Sinclair. "When L'Oréal, Unilever and Mars move together in the same direction, the rest of the market pays attention."

FOR EDITORS

Agentic Commerce Protocols: Comparative View

Dimension OpenAI ACP Google UCP Azoma Agentic Merchant Protocol Primary focus Agent execution & checkout Consumer discovery & checkout Brand representation control, analytics, attribution & multi-agent syndication Structured product data feed Yes Yes Yes Focus on agent-driven checkout Yes Yes No Cross-agent syndication No Partial (across Google agents only) Yes (across agents & open web) Brand & product representation control No Partial (within Google experiences) Yes (enterprise-defined, cross-surface) Agentic content orchestration No Limited orchestration inside Google’s ecosystem Yes (data-driven, cross-surface) Performance analytics (agentic visibility) No Partial (Google surfaces only) Yes Attribution & ROI forecasting No No Yes Onboarding orientation Developer APIs Developer tools Whiteglove for marketing & commerce teams

View source version on businesswire.com: https://www.businesswire.com/news/home/20260312137127/en/

Contacts

Positive: azoma@positivemarketing.com +44 203 637 0640

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Zusammenfassung (ca. 450 Wörter)

Beiersdorf, der Inhaber von Marken wie NIVEA und Hansaplast, steht derzeit unter Druck, nachdem eine vorsichtige Prognose für 2026 veröffentlicht wurde. Trotz des Erhalts stabiler Einnahmen und Umsatzzahlen für 2025 hat die Unternehmensleitung die Verkäufe in der Konsubenheit als langsam vorhergesagt und dies hat zu einem erheblichen Rückgang des Aktienkurses und der Gesamtrendite für Aktionäre geführt.

Das Hauptproblem ist eine Verschiebung der Anlegerstimmung – eine Abkehr von dem Vertrauen in die zukünftige Wachstumstendenz des Unternehmens. Die Unternehmensleitung prognostiziert ein langsameres Umsatzwachstum, was zu Unsicherheiten über die zukünftige Leistung führt.

Die Analyse von Simply Wall St hebt die Möglichkeit hervor, die durch den Aktienkursrückgang entsteht. Da der Aktienkurs gegenüber einigen Analystenschätzungen und Intrinsic Value Berechnungen unterbewertet ist, stellt dies die Frage nach der Möglichkeit einer Investition dar oder ob langsameres zukünftiges Wachstum bereits vollständig in der aktuellen Bewertung widergespiegelt wird.

Derzeit deutet die vorherrschende Erzählung darauf hin, dass das Unternehmen unterbewertet ist, mit einer fairen Wertschätzung von 115,15 € im Vergleich zum aktuellen Aktienkurs von 83,66 €. Dieser Unterschied deutet auf ein erhebliches Potenzial für Investoren hin.

Beiersdorf versucht, diese Bedenken durch eine strategische Verschiebung hin zu Premiumprodukten zu bewältigen – wobei der Schwerpunkt auf Innovationen wie dem NIVEA Epigenetics Serum und dem Einsatz wissenschaftlich fundierter Angebote liegt. Diese Strategie soll die durchschnittlichen Verkaufspreise erhöhen, wiederholte Käufe von Kunden fördern und letztendlich die Gewinnmargen erweitern.

Allerdings steht das Unternehmen vor potenziellen Herausforderungen. Erhöhte Wettbewerbspreise, insbesondere für die NIVEA-Marke, und anhaltender Druck durch Einzelhändler in Europa könnten die Ambitionen des Unternehmens behindern. Die Bewältigung dieser Herausforderungen ist entscheidend für die Erreichung der Vorteile der Premiumisierungsstrategie.

Simply Wall St ermutigt Investoren, ihre eigene Due Diligence durchzuführen. Sie empfehlen, die vollständige Erzählung zu prüfen, die die detaillierten Prognosen darlegt, die die faire Wertschätzung antreiben – diese gehen weit über einfache Bewertungen der Markenstärke hinaus. Die Analyse identifiziert auch wichtige Risiken für die bullische Erzählung und fordert Investoren auf, potenzielle Herausforderungen zu berücksichtigen.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Zusammenfassung (max. 500 Wörter)

Beiersdorf AG (BDRFF), ein global führendes Unternehmen im Bereich der Hautpflege, veröffentlichte gemischte Ergebnisse für 2025 und demonstrierte Widerstandsfähigkeit angesichts eines schwierigen Marktumfelds. Die Gesamtwachstum der organischen Umsätze stieg um 2,4 %, unterstützt durch eine starke Leistung im Consumer Business (8,176 Milliarden) und insbesondere im Derma-Bereich (1,5 Milliarden) mit zweistelligem Wachstum. Die EBIT-Marge stieg auf 14,0 %, was eine verbesserte Rentabilität signalisiert. Der Gewinn pro Aktie stieg auf 4,25, was einem Anstieg von 4,9 % im Jahresvergleich entspricht.

Trotz dieser positiven Aspekte gab es mehrere Herausforderungen. Der globale Hautpflegemarkt erlebte eine Verlangsamung, insbesondere in Schwellenländern wie Osteuropa, was zu einer schwächeren Performance von Nivea (organisches Wachstum von 0,9 %) und zu einem Rückgang der organischen Umsätze von La Prairie um 4,5 % führte. Die Consumer-Bruttomarge sank um 70 Basispunkte auf 60,3 % aufgrund der Expansion in erschwinglichere Produktlinien.

Beiersdorfs Erfolg beruht auf einer strategischen Expansion in „White Spaces“ – erfolgreich in Märkten wie Indien, China und Japan – und kontinuierlicher Investition in Forschung und Entwicklung, die Innovationen wie Eucerins Anti-Pigment-Serum fördert, das jetzt das führende Online-Produkt in China ist.

Allerdings blieb die Liquiditätsumwandlung ein Problem, wobei Working Capital auf über 10 % des Umsatzes anstieg und die finanzielle Flexibilität des Unternehmens beeinträchtigte. Die Veröffentlichung enthält eine „Warnung“ von GuruFocus, die 8 potenzielle Warnzeichen für BDRFF hervorhebt und eine DCF-Rechner-Testung anregt.

Mit Blick auf 2026 erwartet das Unternehmen weiterhin Wachstum in China (optimistisch hinsichtlich des Marktanteils von La Prairie und des Erfolgs von Eucerin), sieht sich aber Herausforderungen in Schlüsselmärkten wie Osteuropa und der anhaltenden Volatilität im Luxussegment (La Prairie) entgegen. Die Prognose deutet auf einen zweistelligen Rückgang der Umsätze von La Prairie im ersten Quartal 2026 aufgrund von Störungen und einer Fokussierung von Nivea auf bestehende Innovationen und einer positiveren Dynamik im zweiten Halbjahr hin.

Wichtige strategische Maßnahmen umfassen die Neuzuweisung von Ausgaben vom Premium-Gesichtspflege in Körper- und erschwingliche Hautpflege-Linien, die Nutzung weniger medienintensiver Kategorien. Das Unternehmen plant außerdem, die Herausforderungen im Osteuropabereich mit neuen Produkten und Initiativen zu bewältigen und einen positiveren Ausblick auf die Region für 2026 zu äußern.